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Abstract
Chitosan nanoparticle could become potential formula to protect protein degradation during therapy, 
since chitosan nanoparticles have “proton sponge hypothesis” mechanism on its protection. Chitosan and pectin 
is used as basic formula of drug delivery because of its biodegradable and biocompatible properties. Chitosan-
pectin nanoparticles can be formulated by polyelectrolit complex. EpCAM showed excessive expression in 
epithelial cancer cells thus can be used as a therapeutic biomarker. MJ protein, a Ribosome-Inactivating Proteins 
(RIPs) isolated from Mirabilis jalapa L had a higher cytotoxicity on malignant cells than normal cells. MJ protein 
need to be formulated to protect from proteosome degradation in endosome. The aim of this research was to 
develop MJ protein-chitosan-pectin nanoparticles and conjugated with anti EpCAM for breast cancer therapy. 
Mj protein was extracted from M.jalapa leaves. RIPs activity was assayed by supercoiled DNA cleavage. MJ 
protein were loaded into chitosan nanoparticles using medium viscous chitosan and pectin as cross-linker with 
polyelectrolit complex method. Anti EpCAM was conjugated to MJ protein-chitosan-pectin nanoparticles by 
carbodiimide reaction and characterized for its entrapment effi ciency, morphology by transmission electron 
microscope, particles size, and zeta potential. MJ protein nanoparticles conjugated anti EpCAM and without 
anti EpCAM were cytotoxicity assayed toward T47D and Vero cell lines. MJ protein was able to cleave the 
supercoiled DNA into linear and nicked-circular ones. The nanoparticles optimal concentration of medium 
viscous chitosan: MJ protein: pectin was 0.01%: 0.01%: 1% (m/v). A high entrapment effi ciency of MJ protein 
nanoparticles was 98.97 ± 0.07%. Morphology nanoparticles showed an amorphic structure with 200.00 nm 
particles size. The nanoparticles conjugated anti EpCAM showed average particles size 367.67nm, polydispersity 
index 0.332, and zeta potential +39.97mV. MJ protein-chitosan-pectin nanoparticles conjugated anti EpCAM 
and unconjugated both had higher cytotoxicity with the IC50 57.64 μg/mL and 46.84 μg/mL respectively 
against T47D and 99.38 μg/mL and 111.34 μg/mL against Vero cell lines compared to MJ protein with IC50 of 
3075.61 μg/mL against T47D and 3286.88 μg/mL against Vero cell lines. Both MJ protein-nanoparticles could 
increase the cytotoxicity effects about 50 times compared to the unformulated MJ protein activity, however 
had less specifi city toward T47D and Vero cell lines.
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Introduction
Drug delivery system with nanoparticles 
have higher potency to raise protein stability 
and duration of therapy effects. It also can 
be applied without injection (Florence, 
1997). Chitosan nanoparticles have “proton 
sponge hypothesis” mechanism, therefore 
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it can protect proteins from degradation in 
endosome (Taira et al., 2005). Chitosan and 
pectin are biocompatible, biodegradable, 
muchoadhesif (Morris et al., 2010; Jana et al., 
2011), and low toxic materials (Yuan et al., 
2009), hence its can be used as drug delivery 
system. 
Carcinogenesis is started from normal 
cells which then become uncontrolly divide 
without differentiate (King and Robins, 2006). 
Chemotherapy is the main choice for cancer 
treatment (McCartney and Turkington, 2002), 
however, it generally have toxic side effect 
toward normal cells and not specifi c only 
for cancer cells (Liao et al., 2013). Therefore, 
delivering drug into the cell target will be 
necessary. Ribosome-inactivating proteins 
(RIPs) are nature cytotoxic compounds 
(De Virgilio et al., 2010). One of them is 
MJ protein, a RIP isolated from Mirabilis 
jalapa L. leaves. MJ protein have shown in 
vitro cytotoxic activity  against cancer cells 
(Ikawati et al., 2003; Ikawati et al., 2006). It also 
had cytotoxic activity against breast-cancer 
cell-lines, T47D (Sismindari et al., 2010). It 
found that MJ protein had higher cytotoxic 
effect against cancer cells than normal cells 
(Stirpe and Battelli, 2006; Sismindari et al., 
2010). In addition, MJ protein had the ability 
to delay the onset of tumorigenesis for 2 
weeks and reduced the incidence of tumor 
and the tumor multiplicity by 40% and 30% 
respectively (Hussaana et al., 2009).  However, 
MJ protein will be unstable when enter the 
cells, and easy being degradated. MJ protein 
need to be formulated as nanoparticle with 
the delivery system to raise it’s stability and 
specifi city toward cancer cells (De Virgilio 
et al., 2010).
Cell Adhesion Molecules (CAM) are 
glycoprotein membrane or transmembrane 
that mediated communication among cells or 
attached cells with its substrates (Vleminckx, 
2001). Breast cancer cells interact among each 
other by cell adhesion proteins. In normal 
physiologis condition, its have a role to 
control cells polarity and restraint epithelial 
cells. When the cells are mutated in its side, 
it can be a triger to adhesion, invasion, and 
migrasion (metastatic) in cancer cells (Offi ah 
et al., 2012). Point mutation are happened 
in E-caderin gene that code CAM. In this 
case, E-cadherin mutation are most found 
in lobular breast cancer (Gullick, 2001). 
Epithelial Cell Adhesion Molecule (EpCAM) 
is cell adhesion protein/molecules that very 
potent to use as targeted therapy in breast 
cancer treatment since it is overexpressed 
in this cells (Osta et al., 2004). Nevertheless, 
based from immunofl uorescence analysis, 
it was reported that anti EpCAM in T47D 
didnot express AUA-1 subtype (Sterzynska 
et al., 2012).
Self-assembled Polyelectrolyte Complex 
Nanoparticles Formed from chitosan and 
pectin nanoparticles as wound dress had been 
characterized. Chitosan-pectin nanoparticles 
could also be formulated by polyelectrolyte 
complex method (PEC) (Birch and Schiffman, 
2014). Cytotoxicity effects of chitosan-pectin 
nanoparticles conjugated antibody toward 
cells needed to be identifi ed  in order to reach 
the specifi c target. In this study, cytotoxic 
activity of MJ proteins nanoparticles was 
analyzed against T47D and Vero cell lines. 
Materials and Methods
Materials
This study used red flower Mirabilis 
jalapa L. leaves from Pogung, Sleman, DIY 
and pET28 plasmids from Microbiology 
Laboratory, Department of Fisheries, Faculty 
of Agriculture, UGM. Medium viscous 
chitosan (Aldrich) and pectin from apple 
(Sigma) were used as polymers to formulate 
the nanoparticles. AUA-1 subclone Anti 
EpCAM antibody (Abcam) were used 
as biomarker. T47D and Vero cell lines 
(ATCC, LPPT UGM) were used in cytotoxic 
assayed.
M. jalapa  leaves were sliced and 
grounded into a powder and homogenized 
in the 5 mM sodium phosphate buffer pH 7.2 
with 0.14 M sodium chloride. The solution 
was fi ltered and subsequently centrifuged in 
9000 x g speed, 40 min, and 4 oC temperature. 
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The protein was precipitated using acetone 
1:1 (v/v) and centrifugated 9000 x g for 45 
min at 4 °C. The protein pellet was dissolved 
in 5mM phosphate buffer pH 6.5 and mixed 
gentlely (modificated from Ikawati et al., 
2003). Proteins concentration were measured 
by Bradford assay.
Proteins concentration were measured 
by formula as follows (Nobel, 2000):
Proteins concentration = concentration x 
dilution
Protein
concentration slope
(average of
absorbance
intercept x dilution
=
-
RIPs Activity Assay
One μg of DNA plasmid (pET28) 
was incubated with various amount of MJ 
proteins (0.05; 0.1; 0.5 mg/mL) at a final 
volume of 10 μL containing 1xTMN buffer at 
30 oC for 1 hour. In the end of reaction, 4μL 
loading buffer were added. Electrophoresis 
was done using 0.8% agarose in 1x TBE 
buffer. DNA bands were visualized using 
ethidium bromide (Ikawati et al., 2006).
Formulation of Nanoparticles
Optimization of nanoparticles formula 
(1:1 w/v)  were done at various concentration 
of chitosan and pectin (Chitosan: 0.01%; 
0.05%; 0.1%; 0.5% and 1%; Pectin: 0.01%; 
0.05%; 0.1%; 0.5%; and 1%). Each of chitosan-
pectin nanoparticles formula were mixed for 
20 sec using vortex (modifi cated from Birch 
and Schiffman, 2014). The best formula was 
opact turbidity and did not clot.
Optimization of BSA nanoparticles (BSA 
as proteins model) were done using optimum 
formula of chitosan-pectin nanoparticles with 
various concentration of BSA concentration, 
0.01%; 0.05%; 0.1%; 0.5%; and 1% (v/v) with 1:1 
(w/v) ratio. Optimum formulas were selected 
from opaque and did not clot formulas.
MJ proteins nanoparticles were 
formulated based on the optimum formula 
of BSA nanoparticles (0.01% chitosan; 1% 
pectin). Various RIPs concentration were 
used in this formulas, 0.05 mg/mL; 0.1 mg/
mL; and 0.2 mg/mL. This nanoparticles were 
formulated in 1:1:1(w/v) ratio of chitosan, MJ 
protein and pectin. The optimum formula of 
this nanoparticles were dialysed overnight.
A n t i  E p C A M  a n t i b o d y  w e r e 
conjugated with optimum formula of MJ 
proteins nanoparticles using 1-Ethyl-3-(3-
dimethylaminopropyl)carbodiimide (EDC) 
reaction. Ten microliters of Anti EpCAM 
antibody 1 mg/mL were reacted with 10 
μL of 1 mg/mL EDC in the addition of 80 
μL MOPS pH 6. Fifty microliters of this 
antibody suspension were reacted with 3 
mL MJ proteins nanoparticles (modifi cated 
from Hoganson et al., 1998), and was dialysed 
overnight at 4 °C.
Nanoparticles Characterization
E n t r a p m e n t  e f f i c i e n c y  o f  M J 
proteins concentration in chitosan-pectin 
nanoparticles, was analyzed by measuring 
the concentration of un-entraped protein 
at nanoparticles using spectrophotometry. 
Chitosan-pectin nanoparticles integrated MJ 
proteins and without MJ proteins (as blanko) 
were centrifuged with 15.000 x g speed in 35 
min to separate nanoparticles and it’s solvent. 
Supernatan were taken to spectrofotometry 
assayed. Proteins concentration were 
measured using Bradford assay. 
Effi ciency concentration of un-entraped 
MJ proteins in chitosan-pectin nanoparticles 
(EE) was  measured as follows (Ranjan et al., 
2012):
Entrapment
Efficeincy RIPs in nanoparticles
suspension
RIPs residue
in nanoparticles
suspension x100
= /
/
Amount of RIPs residue in nanoparticles 
suspension were measured by formula as 
follows (Ranjan et al., 2012):
∑ RIPs residue = ∑ RIPs in nanoparticles 
suspension - proteins concentration
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Morphology character of nanoparticles 
surface were observed by Transmission 
Electron Microscope (TEM). A droplet of 
poly-ion complex nanoparticles suspension 
were droped on a layer of carbon fi lm on 
copper net. It droplet were coloured by 
Sodium (K) Phosphotungstate (PTA). Then, 
that droplet were observed by TEM (Jang 
and Nah, 2003).
The nanoparticles were mixed in 
deionized water. It was meant to measured 
the diameters and particles distribution 
(polydispersity index) that were measured 
by photon corelated in spectroscopy by 
Particle Size Analyzer. Particles charge were 
qualifi ed as zeta potential by anemometri 
laser Doppler. All of this measured were done 
in triple measured (Kocbek et al., 2007).
Cytotoxicity Assay
Following starvation, 5x104 cells/mL of 
T47D and Vero cell lines were treated with 
100 μL of conjugated anti EpCAM-chitosan-
pectin-MJ protein nanoparticles (33.33 μg/
mL); chitosan-pectin-MJ protein nanoparticles 
(33.33 μg/mL); unformulated MJ proteins 
(1000 μg/mL; and 100μL) and Doxorubicin 
(10 μg/mL). Cells were incubated at 37 
oC for 24 hours in 5% CO2. After 24 hours 
incubated, cells were washed and added 
with 100 μL of fresh media contained 5 mg/
mL MTT ((3-(4,5-dimethyltiazol-2-il)-2,5-
diphenyl tetrazolium bromide) reagen. Cells 
were then incubated for 3 hours at 37 oC in 
CO2 incubator, followed by the addition of 
100μL of stopper solution. The formation of 
dark broun-purple colour were measured 
on λ 550 nm. IC50 values were calculated by 
probit analysed. Percetage of death cells were 
measured with formula as follows (Ikawati 
et al., 2006):
%death cells
A
A A x100
control cells
control cell cel treated= -
Cells morphology were observed by 
inverted microscope. Cytotoxic effect were 
observed by curve of % death cells and IC50. 
Inhibitory concentration were measured with 
probit analysed by SPSS programme (Ikawati 
et al., 2006).
Results and Discussion
Ribosome-inactivating proteins (RIPs) 
extraction from M.jalapa L leaves obtained 
about 40% (123.25 mg) of MJ protein. 
proteins. RIPs activity assays in MJ proteins 
were assayed by supercoil (DNA pET-28) 
cleaved methods. Proteins concentrations 
that were used for analysis were 0.05 mg/
mL; 0.1 mg/mL; and 0.5 mg/mL. The 
results demonstrated that MJ protein was 
able to cleave the supercoiled DNA into 
nick sircular and linear form as shown 
at Figure 1. Therefore, it was indicated 
that the protein was in an active form. At 
higher MJ proteins concentration (0.5 mg/
mL), had a higher RIPs cleavage activity, 
which resulted in the pDNA degradation. 
This results supported the previous work, 
where at low concentration, RIPs was able to 
cleave supercoiled DNA into a nick circular. 
At the increasing RIPs concentration, the 
supercoiled DNA form will be disappeared 
and the linear form produced followed by the 
degradation of DNA at higher concentration 
(Sismindari et al., 1998)
Nick circular DNA migrate slower than 
linear DNA, and both of them migrate slower 
than control, supercoiled DNA (Figure 
1). MJ proteins showed good condition 
Figure 1. Electrophoregram of RIPs activity assayed (K 
: control; 0.05, 0.1, and 0.5 : plasmid with MJ proteins 
extracts). It showed 3 kinds of DNA bands A. Supercoil 
DNA, B. Nick circular DNA, C. Linear DNA   
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and contained active RIPs, then it could 
be further formulated in chitosan-pectin 
nanoparticles.  
Optimization of nanoparticle formula 
was carried out with a various chitosan 
concentration as matrixes and pectin as 
crosslinked at the same concentrations, range 
from 0.01% to 1% (w/v). Each concentration 
were mixed at 1:1 (v/v) ratio to fi nd out a 
stable nanoparticles. The results indicated 
that there were two optimum nanoparticles 
formulas, that were at the chitosan and pectin 
concentration of 1% : 0.05% and 0.01% : 1% 
respectively (Table 1). This result based on the 
opact turbidity of suspensions observation, 
which indicated the nanoparticles formation 
as a micro or macroparticle. 
Polyelectrolyte complex (PEC) is formed 
between chitosan polycationic that bring 
positive charge (NH3+) and pectin polyanionic 
that bring negative charge (-COO-). On the 
appropriate concentration ratio, chitosan and 
pectin would form nanoparticles that signed 
as opact turbidity. When the concentration 
was too low, the suspension will be pellucid, 
it would not be formulated as polyelectrolyte 
complexes. Whereas, when the concentration 
is too high, the polyelectrolyte complexes 
would become more viscous, so it would be 
formed as micro or macroparticles that  was 
signed as precipitation in suspension.
Optimization of BSA concentrations 
as proteins model for BSA-nanoparticles 
were formulated according to the candidate 
formula (Table 1), at chitosan:pectin 
concentration of 0.01% : 1  and 1% : 0.05%. BSA 
is often used as drug model in drug delivery 
systems because of it’s stable structure and 
thermostable characteristic (Odunuga and 
Shazhko, 2013). The BSA concentration that 
were used in this formula, were 0.2% to 
1%. The result indicated that nanoparticle 
formula with 1% BSA was precipitated after 
3 days storage. Pellucid suspension was 
formed at all of chitosan:pectin concentration 
1% : 0.05% formulas. There were not formed 
PEC in all of BSA concentration (0.2% 
and 1%), it meant that it were not formed 
nanoparticles. It probably caused by the 
used of high methoxyl pectin. This pectin has 
more metoxyl groups than carboxyl groups, 
which could reduced the negative charges 
of pectin chains. If pectin concentration was 
less than chitosan, so that carboxyl groups 
of pectin will less and the amine groups in 
chitosan chains will over abundant. Hence, 
chitosan would not be able to react with 
pectin, then it could not form PEC. Based 
on the result, the chosen formula would be 
chitosan:pectin concentration of 0.01% : 1% 
with the BSA concentration of 0.2%. In this 
pectin’s concentration that over abundant 
(1%) than chitosan’s concentration (0.01%), 
both of its polymers would form stable PEC.
This results was then used as a basic for 
formulating the MJ protein-chitosan-pectin 
nanoparticle. 
MJ protein at various concentration, 
0.05 mg/mL, 0.1 mg/mL, and 0.2 mg/
mL was formulated using the candidate 
nanoparticle formula, with the chitosan-
pectin concentration at 0.01% : 1%. The result 
demonstrated that these formulas with the 
1:1:1 ratio (v/v) showed similar turbidity. 
Particles dispersion shown opact 
turbidity after its were formulated. Protein 
Table 1. Optimization chitosan-pectin nanoparticles formula.  
Pectin Chitosan
0.01% 0.05% 0.1% 0.5% 1%
0.01% pellucid   pellucid    Pellucid    Pellucid     Pellucid
0.05% pellucid   Pellucid    Pellucid    Pellucid     Opact*
0.1% pellucid Precipitated  precipitated  precipitated   precipitated
0.5% pellucid Precipitated  precipitated  precipitated   precipitated
1% Opact* Precipitated  precipitated  precipitated   precipitated
Note: candidate formula are indicated with star (*)
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concentrations that was chosen were 
the highest concentration that could be 
formulated into stable nanoparticles. MJ 
protein concentrations that was chosen 
was 0.1 mg/mL, since at the MJ protein 
concentration of 0.2  mg/mL, the formula 
was precipitated after one week storage 
in 4 to 10o C. Morphology of MJ protein 
nanoparticles was observed by TEM. It 
shown amorphic structure of nanoparticles 
with 200.0nm diameter (Figure 2).This 
concentration was expected to form stable 
nanoparticle when conjugated with anti 
EpCAM. The MJ protein nanoparticles were 
stable in 4 to 10 °C during 2 to 3 weeks 
storage.
MJ protein nanoparticles and anti 
EpCAM were conjugated by carbodiimede 
reaction with EDC as space linker. EDC 
activated carboxyl groups in pectin, thus 
it can bind to amin groups of anti EpCAM. 
Entrapment efficiency of MJ protein 
nanoparticles was 98.97 ± 0.07%. 
Figure 2. Visualization of MJ protein nanoparticle’s 
morphology
Figure 3. Cytotoxic effect of nanoparticle formulated and un-formulated MJ protein against 
T47D and Vero cell lines. 
Both cells-lines (5x104 cells/mL) were treated with formulated and un-formulated MJ-protein 
nanoparticle at various concentration with the incubated at 37oC for 3 hours. The cell death was 
visualized by measuring the dark broun-purple colour using ELISA reader at λ 550 nm.
A. Formulated MJ protein nanoparticle and MJ-protein immuno-nanoparticle
B. Un-formulated MJ protein 
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Following immuno-nanoparticles 
formulation, diameter of nanoparticles 
were measured by particle size analyzer 
(PSA). Diameter of MJ protein nanoparticles 
conjugated anti EpCAM was 367.67 nm, 
which was longer than the diameter of 
unconjugated MJ-nanoparticle. This diameter 
was similar to polylactic-co-glycolic acid 
(PLGA) nanoparticles, which was 320-360nm 
(Kocbeck et al., 2007). It was indicated that the 
conjugated MJ nanoparticle was obtained.
Further analysis was carried out by 
measuring the polydispersity index (P.I). It 
was indicated that the average P.I of immuno-
nanoparticles was 0.332. The value was close 
to zero, so that it refers to more monodispers 
(Ranjan et al., 2012). Zeta potential of MJ 
protein immune-nanoparticles was +39,97 
mV, it mean that  this nanoparticles had a high 
positive charge, so that, this nanoparticles 
could attach the negatively charge of the cells 
membrane and enter the cells easily.  
The cytotoxicity analysis indicated that 
the MJ-protein-nanoparticle and MJ-protein 
immuno-nanoparticle had more cytotoxic 
against T47D cells than Vero cells (Figure 
3A). At the concentration of 2.85 μg/mL, 
MJ-protein-nanoparticle and MJ-protein 
immuno-nanoparticle had cytotoxic effects 
of 34.71%, 35.29% respectively against T47D 
and 9.02%, 20.87% respectively against Vero 
cells line (Figure 3B). Similar pattern was 
also occurred on MJ protein, it had higher 
cytotoxicity against T47D (31% cell death 
at 125 μg/mL) compared to Vero cell lines 
(11.40% at 125 μg/mL). 
Calculated IC50 (Figure 4) clearly 
demonstrated that either formulated MJ-
protein nanoparticle had slightly higher 
cytotoxicity (IC50 of 46.84 μg/mL) compared 
to MJ-protein immuno-nanoparticle (IC50 of 
57.64 μg/mL) and both of them had higher 
cytotoxicity, compared to un-formulated 
MJ protein with the IC50 of 2902.70 μg/mL 
against T47D. Similar results, both MJ-protein 
nanoparticle and MJ-protein immuno-
nanoparticle had  higher cytotoxicity against 
Vero cells with the IC50 of  values 99.38 μg/mL 
and  111.34 μg/mL respectively, compared 
to un-formulated MJ protein with the IC50 of 
3286.88 μg/mL (Figure 4). 
Unfortunately, there were no difference 
cytotoxic activity between MJ-protein-
nanoparticle and MJ-protein immuno-
nanoparticle, as indicated by the slightly 
differences between their IC50 values. It 
probably caused by no interaction process 
between antibody anti EpCAM type AUA-1 
with EpCAM of T47D cells. It seem that 
EpCAM of T47D could strong interact with 
antibody anti EpCAM type EBA-1 and 
moderate interaction with the type 9C4 
(Sterzynska et al., 2012). On the other side, the 
higher cytotoxicity of these formulas against 
Vero cells were suspected that it has EpCAM 
receptor. EpCAM expression in ductal ren 
were 71% (Went et al., 2008). It probable 
affected a higher cytotoxicity of MJ protein 
Figure 4.  Calculated IC50 of formulated MJ protein and un-formulated MJ protein against 
T47D and Vero cell lines
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nanoparticles conjugated anti EpCAM in 
Vero cells than it nanoparticles without anti 
EpCAM.
In addition,  although the ideal 
nanoparticle sizes for nanotherapy are range 
from 1 to 100nm for easy internalization into 
the cells, however, for drug delivery system 
the size could be tolerated to 400 nm (Rao et 
al. 2010), and the MJ-protein nanoparticles 
size was 200 nm, so that it could still pass 
the capiler safely, as indicated by the high 
cytotoxicity (low IC50 value) against T47D 
and Vero cells-line.
The higher IC50 values obtained from 
un-formulated MJ protein compared to 
previous work (111 μg/mL) that was done 
by Sismindari et al. (2010), could probable be 
caused by the period length of incubation. 
In this experiment the incubation was done 
for 3 hours, whereas at previous work was 
48 hours. In addition, it was found that the 
activity was also depended on the size of 
the nanoparticle. Formulated MJ protein 
using low viscosity-alginate which produced 
smaller nanoparticles size (130.73 nm) with 
zeta potential of +26,36 mV, had an IC50 of 
14.87 μg/mL against T47D cell line and 27.84 
μg/mL against Vero cell line (Wicaksono, 
2014). Smaller size of this nanoparticle 
probable affected it to endosite easierly, thus 
it’s IC50 values could be fulfi lled. 
Conclusion
Medium viscousity Chitosan-pectin 
nanoparticles could be formulated with 
MJ proteins (MJ protein-nanoparticle) had 
EE value of 98.97 ± 0.07%, diameter 200.00 
nm, and amorphic structure. Conjugated 
the MJ protein medium viscousity-chitosan-
pectin nanoparticles with anti EpCAM (MJ 
protein-immuno-nanoparticle) produced 
nanoparticle with a diameter of 367.67 nm, 
PI 0.332, and zeta potensial +39.97 mV. The 
formulated MJ protein-nanoparticles or MJ 
protein-immuno-nanoparticle could increase 
the cytotoxicity effects about 50 times 
compared to the unformulated MJ protein 
activity. However, there were less specifi city 
of anti EpCAM AUA-1 MJ-protein immuno-
nanoparticle cytotoxic activity between T47D 
and Vero cell lines.
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